AC
SNDX icon

AXQ Capital’s Syndax Pharmaceuticals SNDX Stock Holding History

AXQ Capital’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$428K Buy
+18,340
New +$399K 0.06% 465

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

AXQ Capital's SNDX Position: Q1 2026 in Review

AXQ Capital opened a new position in Syndax Pharmaceuticals (SNDX) in Q1 2026: 18,340 shares worth $428K. The stake represents 0.06% of the portfolio and ranks #465 among its holdings.

246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • AXQ Capital held 18,340 shares of Syndax Pharmaceuticals worth $428K as of Q1 2026.
  • Syndax Pharmaceuticals was a new AXQ Capital position in Q1 2026.
  • Syndax Pharmaceuticals made up 0.06% of AXQ Capital's portfolio in Q1 2026, its #465 holding.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.